JP2022530095A5 - - Google Patents
Info
- Publication number
- JP2022530095A5 JP2022530095A5 JP2021563234A JP2021563234A JP2022530095A5 JP 2022530095 A5 JP2022530095 A5 JP 2022530095A5 JP 2021563234 A JP2021563234 A JP 2021563234A JP 2021563234 A JP2021563234 A JP 2021563234A JP 2022530095 A5 JP2022530095 A5 JP 2022530095A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- raav
- seq
- mirna target
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962837947P | 2019-04-24 | 2019-04-24 | |
| US62/837,947 | 2019-04-24 | ||
| PCT/US2020/029642 WO2020219766A1 (en) | 2019-04-24 | 2020-04-23 | Compositions useful in treatment of rett syndrome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022530095A JP2022530095A (ja) | 2022-06-27 |
| JP2022530095A5 true JP2022530095A5 (cg-RX-API-DMAC7.html) | 2023-04-28 |
Family
ID=72941315
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021563234A Pending JP2022530095A (ja) | 2019-04-24 | 2020-04-23 | レット症候群の治療に有用な組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220202960A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3973060A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022530095A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220003553A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114026236A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020261051A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3133889A1 (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202111279QA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020219766A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL298138A (en) * | 2020-05-12 | 2023-01-01 | Univ Pennsylvania | Compositions for drg-specific reduction of transgene expression |
| WO2022094078A1 (en) * | 2020-10-28 | 2022-05-05 | The Trustees Of The University Of Pennsylvania | Compositions useful in treatment of rett syndrome |
| KR20240100490A (ko) * | 2021-10-18 | 2024-07-01 | 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 | Cdkl5 결핍 장애(cdd)의 치료에 유용한 조성물 |
| WO2023205657A2 (en) * | 2022-04-18 | 2023-10-26 | City Of Hope | Compositions for restoring mecp2 gene function and methods of use thereof |
| US20260139232A1 (en) * | 2022-10-10 | 2026-05-21 | Passage Bio, Inc. | Method of purifying full recombinant aav particles |
| CN121175427A (zh) * | 2023-05-15 | 2025-12-19 | 上海金珂博生物技术有限公司 | 一种Rett综合症的基因治疗 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070099196A1 (en) * | 2004-12-29 | 2007-05-03 | Sakari Kauppinen | Novel oligonucleotide compositions and probe sequences useful for detection and analysis of micrornas and their target mRNAs |
| DK2002003T3 (en) * | 2005-05-27 | 2016-03-21 | Ospedale San Raffaele Srl | Gene vector comprising miRNA |
| DK2010563T3 (da) * | 2006-04-07 | 2011-05-23 | Univ Goettingen Georg August | Syntetisk MeCP2 sekvens til proteinsubstitutionsterapi |
| US9415121B2 (en) * | 2008-12-19 | 2016-08-16 | Nationwide Children's Hospital | Delivery of MECP2 polynucleotide using recombinant AAV9 |
| WO2013151664A1 (en) * | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins |
| WO2017191274A2 (en) * | 2016-05-04 | 2017-11-09 | Curevac Ag | Rna encoding a therapeutic protein |
| TW201837170A (zh) * | 2017-02-28 | 2018-10-16 | 賓州大學委員會 | 新穎aav媒介的流感疫苗 |
| RS65241B1 (sr) * | 2017-02-28 | 2024-03-29 | Univ Pennsylvania | Vektor adeno-asociranih virusa (aav) iz podgrupe f i njegove upotrebe |
| RU2019133002A (ru) * | 2017-03-24 | 2021-04-26 | Зе Юнивёрсити Корт Оф Зе Юнивёрсити Оф Эдинбург | ЭКСПРЕССИОННЫЕ КАССЕТЫ MeCP2 |
| EP3635122A4 (en) * | 2017-06-06 | 2021-03-31 | University of Massachusetts | SELF-REGULATING AAV VECTORS FOR THE SAFE EXPRESSION OF MECP2 IN RETT SYNDROME |
-
2020
- 2020-04-23 WO PCT/US2020/029642 patent/WO2020219766A1/en not_active Ceased
- 2020-04-23 SG SG11202111279QA patent/SG11202111279QA/en unknown
- 2020-04-23 EP EP20795847.1A patent/EP3973060A4/en not_active Withdrawn
- 2020-04-23 KR KR1020217037510A patent/KR20220003553A/ko active Pending
- 2020-04-23 CN CN202080046692.7A patent/CN114026236A/zh active Pending
- 2020-04-23 CA CA3133889A patent/CA3133889A1/en active Pending
- 2020-04-23 AU AU2020261051A patent/AU2020261051A1/en not_active Abandoned
- 2020-04-23 US US17/605,827 patent/US20220202960A1/en not_active Abandoned
- 2020-04-23 JP JP2021563234A patent/JP2022530095A/ja active Pending